Press release
PREMIER Biosoft and MRC-Holland form an alliance
PREMIER Biosoft International, a leading bioinformatics company, and MRC-Holland, the inventors of MLPA® technology, announced an alliance. Multiplex Ligation-dependent Probe Amplification (MLPA®) is a method to establish the copy number of up to 45 nucleic acid sequences in a single reaction. Detecting copy number changes in the genome, the primary application of MLPA® technology, is a widely researched area. Current efforts are directed towards more comprehensive cataloging and characterization of these changes. MLPA® probes are able to discriminate between sequences that differ by just one nucleotide, making them a highly sensitive and precise tool for detecting the changes. It is rapidly becoming the most favored among the currently used methods.The alliance will help MLPA® users design custom oligos for genes that do not have kits available. Currently, no such design tool exists. "With this collaboration, both PREMIER Biosoft and MRC-Holland will use their core competencies and expertise to develop a powerful bioinformatics tool for MLPA® users." commented Kay Brown, V.P. Business Development and Marketing.
About PREMIER Biosoft International:
Founded in 1994, the company is a group of computer scientists and molecular biologists dedicated to producing cutting-edge intuitive software for the molecular biologist. The goal of the company is to study the most recent innovations in molecular biology and translate them into software products that aid biologists. Additional information about PREMIER Biosoft International is available at http://www.PremierBiosoft.com
About MRC-Holland
MRC-Holland published its first article about MLPA® technology in 2002 and since then, its product range has grown explosively. The company now offers well over a 100 different MLPA® tests for a wide range of applications, from rare genetic diseases to tumor analysis. MRC-Holland aims to make the MLPA® technology available to all scientists and works in close collaboration with researchers around the world. More information about MRC-Holland can be found on www.MLPA.com.
Contact:
Arun Apte
PREMIER Biosoft International
650-856-2703
http://www.PremierBiosoft.com
PREMIER Biosoft International
Founded in 1994, is a group of computer scientists and molecular biologists dedicated to producing cutting edge intuitive software for the molecular biologist. Our goal is to study the most recent innovations in molecular biology and translate them into software products that aid the biologist.
PREMIER Biosoft International
3786 Corina Way
Palo Alto, CA 94303-4504
Phone:650-856-2703
Fax: 650-618-1773
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PREMIER Biosoft and MRC-Holland form an alliance here
News-ID: 14035 • Views: …
More Releases for MLPA
Emerging Trends to Drive Neurogenetic Testing Market Growth at 13.5% CAGR Throug …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Neurogenetic Testing Market Size Growth Forecast: What to Expect by 2025?
Recently, there has been a swift development in the neurogenetic testing market size. The market is set to expand from $0.61 billion in 2024 to $0.7 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.9%.…
Neurogenetic Testing Market Anticipated To Witness Robust Growth, Surpassing $1. …
The Neurogenetic Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Neurogenetic Testing Market Size and Its Estimated Growth Rate?
The neurogenetic testing market has seen fast growth. It will grow from $0.61 billion in 2024 to $0.7 billion in 2025 at…
Rising Prevalence Of Neurological Disorders Fuels Demand For Neurogenetic Testin …
Which drivers are expected to have the greatest impact on the over the neurogenetic testing market's growth?
The increasing prevalence of neurological disorders is also expected to propel the growth of the neurogenetic testing market. These disorders affect the nervous system and can arise from genetic factors, infections, trauma, or degeneration. Neurogenetic testing offers valuable insights into the genetic risk factors of these conditions, guiding treatment choices and improving patient care.…
Neurogenetic Testing Market Poised for 13.5 % Growth, Set to Hit $21 Billion by …
How Is the Neurogenetic Testing Market Projected to Grow, and What Is Its Market Size?
The market size for neurogenetic testing has expanded considerably in the last few years. Its expansion will continue, with an increase from $0.61 billion in 2024 to $0.7 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.9%. Factors contributing to the growth during the historic period include a surge in neurological disease…
Global Neurogenetic Testing Market Impacting Factor's Research Report 2022- MRI, …
The Neurogenetic Testing Market is expected to grow at a stupendous rate in the next 10 years. The healthcare industry is being driven by innovation. The very idea of "Customer is the King" is being implemented. As such, healthcare IT solutions come across as a meticulous and complex system that constitutes interconnected and large-scale systems wherein micros are being worked upon. These would be the facets of the healthcare vertical…
PREMIER Biosoft International releases AlleleID version 7.01 offering enhanced s …
Palo Alto, California – March 5, 2009 PREMIER Biosoft International today announced the world wide release of AlleleID version 7.01. AlleleID, the suite for qPCR and microarrays, now includes support for the latest design guidelines laid down by MRC-Holland, the inventors of the technology. MLPA® is an easy-to-use molecular biology technique which has been gaining attention especially for studies of DNA copy number changes.
With this release, AlleleID now also…
